Browsing: low testosterone

Shah, whose company developed the oral testosterone drug Kyzatrex, urged regulators to broaden treatment access and align policy with modern science and preventive healthcare goals.

Hypogonadism, a condition characterized by low testosterone levels, has become increasingly prevalent in the United States.